Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.01 and traded as high as $0.01. Evofem Biosciences shares last traded at $0.01, with a volume of 52,362 shares traded.
Evofem Biosciences Stock Down 3.1 %
The stock has a market capitalization of $1.08 million, a PE ratio of -0.02 and a beta of -0.90. The business’s 50-day moving average is $0.01 and its two-hundred day moving average is $0.01.
Evofem Biosciences Company Profile
Evofem Biosciences, Inc, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.
Further Reading
- Five stocks we like better than Evofem Biosciences
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- 3 Warren Buffett Stocks to Buy Now
- How Do Stock Buybacks Affect Shareholders?
- Are Penny Stocks a Good Fit for Your Portfolio?
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
